Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD133+ Selected Stem Cell Rescue in High-Risk Neuroblastoma
NCT00539500Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2007
- Primary completion
- Sep 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous CD133+ hematopoietic progenitor cells in neuroblastoma, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2007; status: terminated.
02
Drugs
autologous CD133+ hematopoietic progenitor cells
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00539500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539500.